HRH3 and depressive symptom measurement: The broad spectrum of activities of H3R antagonists continues to expand as more and more novel therapeutic roles have been investigated including Parkinson's disease, multiple sclerosis, cerebral ischaemia, depression, etc., and hence identification of potential clinical targets.